Department published revised Pharmaceutical Benefits Scheme Minimum Stockholding Guidelines

The Department has published an updated version of the Pharmaceutical Benefits Scheme Minimum Stockholding Guidelines (the Guidelines). Updates have been made based on recommendations made in the 12-month review of the Minimum Stockholding Requirements (MSR). Key updates include: New section Section 6.3 - Assessing applications based on short shelf-life. New Section 4.7 - The department’s approach to designated brands that are undergoing trade name changes (‘rebranding’). New section 4.1 - demand variation. Revised Section 8.1 - Approach to Compliance. Revised Section 8.3 - Additional matters added that the Minister may consider when an Responsible Person is non-compliant e.g. stock in transit, loss of significant supply contract.